Saik Andrew
SEC-identified person · CIK 1616284 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Arvinas, INC. AVRN | Chief Financial Officer | filed 2024–2026 |
| Milestone Pharmaceuticals Inc. MIST | Director | filed 2024–2026 |
| Intercept Pharmaceuticals, INC. ICPT | EVP & Chief Financial Officer | filed 2021–2023 |
| Vyne Therapeutics Inc. VYNE | Chief Financial Officer | filed 2020–2021 |
| PDS Biotechnology Corp PDSB | Director · Chief Financial Officer | filed 2017–2020 |
| Auxilium Pharmaceuticals INC AUXL | CFO | filed 2014–2015 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.